Literature DB >> 1851187

Cortical activation in profoundly deaf patients during cochlear implant stimulation demonstrated by H2(15)O PET.

H Herzog1, A Lamprecht, A Kühn, W Roden, K H Vosteen, L E Feinendegen.   

Abstract

Cochlear implants (CIs) are used to provide sensations of sound to profoundly deaf patients. The performance of the CI is assessed mainly by the subjective reports of patients. The aim of this study was to look for objective cortical responses to the stimulation of the CI. Two postlingually and two prelingually deaf patients were investigated by positron emission tomography (PET) using 15O-labeled water (H2(15)O) to determine the regional cerebral blood flow (rCBF). Instead of quantifying rCBF in absolute terms, it was estimated by referring the regional tissue concentration of H2(15)O to the mean whole brain concentration. CI stimulation encoded from white noise and sequential words led to an increased rCBF in the primary and secondary (Wernicke) auditory cortex. Relative elevations of up to 33% were observed bilaterally, although they were higher contralateral to the CI. These results were obtained not only in the postlingually deaf patients but also in two patients who had never been able to hear. Thus, it could be demonstrated that PET measurements of cerebral H2(15)O distribution yield objective responses of the central auditory system during electrical stimulation by CIs in profoundly deaf patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851187     DOI: 10.1097/00004728-199105000-00005

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  14 in total

1.  PET imaging of cochlear-implant and normal-hearing subjects listening to speech and nonspeech.

Authors:  D Wong; R T Miyamoto; D B Pisoni; M Sehgal; G D Hutchins
Journal:  Hear Res       Date:  1999-06       Impact factor: 3.208

Review 2.  Cochlear implants and brain stem implants.

Authors:  Richard T Ramsden
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

3.  Nuclear medicine 2000.

Authors:  O Schober
Journal:  Eur J Nucl Med       Date:  1992

4.  Cortical perfusion response to an electrical stimulation of the auditory nerve in profoundly deaf patients: study with technetium-99m hexamethylpropylene amine oxime single photon emission tomography.

Authors:  Y Le Scao; A Robier; J L Baulieu; P Beutter; L Pourcelot
Journal:  Eur J Nucl Med       Date:  1992

5.  Selective Neuronal Activation by Cochlear Implant Stimulation in Auditory Cortex of Awake Primate.

Authors:  Luke A Johnson; Charles C Della Santina; Xiaoqin Wang
Journal:  J Neurosci       Date:  2016-12-07       Impact factor: 6.167

6.  Auditory cortical activation and plasticity after cochlear implantation measured by PET using fluorodeoxyglucose.

Authors:  Zuzanna Łukaszewicz-Moszyńska; Magdalena Lachowska; Kazimierz Niemczyk
Journal:  Funct Neurol       Date:  2014 Apr-Jun

7.  Reliability of low-frequency auditory stimulation studies associated with technetium-99m hexamethylpropylene amine oxime single-photon emission tomography.

Authors:  Y Le Scao; J Jezequel; A Robier; J L Baulieu; A Turzo; B Guias; P P Morin
Journal:  Eur J Nucl Med       Date:  1993-05

8.  Objective measures of electrode discrimination with electrically evoked auditory change complex and speech-perception abilities in children with auditory neuropathy spectrum disorder.

Authors:  Shuman He; John H Grose; Holly F B Teagle; Craig A Buchman
Journal:  Ear Hear       Date:  2014 May-Jun       Impact factor: 3.570

9.  Cochlear implants stimulate activity-dependent CREB pathway in the deaf auditory cortex: implications for molecular plasticity induced by neural prosthetic devices.

Authors:  Justin Tan; Sandra Widjaja; Jin Xu; Robert K Shepherd
Journal:  Cereb Cortex       Date:  2007-12-05       Impact factor: 5.357

Review 10.  Cochlear implants and brain plasticity.

Authors:  James B Fallon; Dexter R F Irvine; Robert K Shepherd
Journal:  Hear Res       Date:  2007-09-01       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.